| Literature DB >> 26628049 |
Nancy L Schoenborn1, Cynthia Boyd2, Danelle Cayea3, Kelly Nakamura4, Qian-Li Xue5, Anushree Ray6, Matthew McNabney7.
Abstract
BACKGROUND: Prognosis is a critical consideration in caring for older adults with multiple chronic conditions, or "multimorbidity". Clinicians are not adequately trained in this area. We describe an innovative curriculum that teaches internal medicine residents how to incorporate prognosis in the care of older adults with multimorbidity.Entities:
Mesh:
Year: 2015 PMID: 26628049 PMCID: PMC4665923 DOI: 10.1186/s12909-015-0488-x
Source DB: PubMed Journal: BMC Med Educ ISSN: 1472-6920 Impact factor: 2.463
Learner objectives and corresponding evaluation strategies
| Objectives | Evaluation strategies |
|---|---|
| Acceptability | - Post-only acceptability survey of the Intervention group |
| - Rate the curriculum as acceptable and relevant. | |
| Attitude | - Pre/post survey (Impact Survey) of Intervention and Control groups |
| - Rate incorporating prognosis to inform clinical decisions as important in the care of older adults with multimorbidity. | |
| Knowledge/Skills | - Pre/post survey (Impact Survey) of Intervention and Control groups |
| - Demonstrate assessment of prognosis using evidence-based tools. | |
| - Demonstrate application of prognosis to inform clinical decisions. | |
| - Be able to communicate prognosis a) as incorporated into the benefits/harms discussion related to a clinical decision, and b) explicitly in a discussion | |
| Behavior | - Pre/post chart review of Intervention and Control groups for prognosis documentation |
| - Routinely incorporate prognosis to inform clinical decisions in the care of older adults with multimorbidity. |
Assessment of the curriculum’s impact on attitude, knowledge, and self-reported skills, comparing intervention group at baseline vs. at follow-up and intervention group vs. control group at follow-up
aComparison 1 is between intervention group at baseline vs. at follow-up. Comparison 2 is between intervention group and control group at follow-up
bPrognosis estimates (mortality risk in percentages) were compared to the estimates derived using the Lee index and the Schonberg index [32, 33]
Chart review results-- patient characteristics and prognosis documentation in the intervention and control groups
| Intervention | Control |
| ||
|---|---|---|---|---|
| Patient characteristics | ||||
| Number of patients involved in reviewed charts |
|
| ||
| Patient age, mean (SD), year | 68.9 (7.7) | 70.0 (8.3) | 0.58 | |
| Female patient, number (%) | 23 (47 %) | 42 (67 %) | 0.05 | |
| Patient race, number (%) | ||||
| - White | 31 (63 %) | 2 (3 %) | <0.001 | |
| - African American | 12 (24 %) | 56 (89 %) | <0.001 | |
| - Other | 6 (12 %) | 5 (8 %) | 0.53 | |
| Number of chronic conditions a, mean (SD) | 4.0 (1.7) | 3.3 (1.4) | 0.02 | |
| Number of medications, mean (SD) | 11.1 (5.9) | 10.4 (6.0) | 0.52 | |
| Documentation results | ||||
| Number of charts reviewed |
|
| ||
| Overall prognosis | Baseline | 1/25 | 0/25 | >0.99 |
| Follow-up | 8/46 | 0/46 | 0.006 | |
| Cancer screening | Baseline | 15/25 | 13/25 | 0.78 |
| Follow-up | 17/46 | 26/46 | 0.09 | |
| Overall prognosis documentation among charts that documented cancer screening | Baseline | 0/15 | 0/13 | >0.99 |
| Follow-up | 3/17 | 0/26 | 0.06 | |
aOut of 30 conditions in the Elixhauser comorbidity index [34]